Sponsor pipeline

Pharmacyclics Switzerland GmbH clinical trial pipeline

Get alerts when Pharmacyclics Switzerland GmbH's trials change

1 active trials 0 recruiting 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 4
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT03229200 Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. Lymphoma, B-Cell Active, Not Recruiting 2025-10-30

Disease areas by active trials

Leukemia (1)

Get alerts when Pharmacyclics Switzerland GmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free